Leader of the Oxford University and AstraZeneca-backed trial, Professor Andrew Pollard says the team is ‘optimistic’ about getting the go-ahead for the ‘miracle’ vaccine by Christmas time. The academic says their anti-viral would be ten times cheaper than Pfizer ‘s product…

NEW YORK — Pfizer and German company BioNTech announced on Monday, November 9, that their coronavirus vaccine is more than 90 percent effective in preventing COVID-19 in those who have not previously been infected with the virus. Reuters reports that…